Cargando…
Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery
Preoperative prediction of recurrence outcome in hepatocellular carcinoma (HCC) facilitates physicians’ clinical decision-making. Preoperative imaging and related clinical baseline data of patients are valuable for evaluating prognosis. With the widespread application of machine learning techniques,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686395/ https://www.ncbi.nlm.nih.gov/pubmed/36439437 http://dx.doi.org/10.3389/fonc.2022.1019009 |
_version_ | 1784835737469845504 |
---|---|
author | Wang, Liyang Wu, Meilong Zhu, Chengzhan Li, Rui Bao, Shiyun Yang, Shizhong Dong, Jiahong |
author_facet | Wang, Liyang Wu, Meilong Zhu, Chengzhan Li, Rui Bao, Shiyun Yang, Shizhong Dong, Jiahong |
author_sort | Wang, Liyang |
collection | PubMed |
description | Preoperative prediction of recurrence outcome in hepatocellular carcinoma (HCC) facilitates physicians’ clinical decision-making. Preoperative imaging and related clinical baseline data of patients are valuable for evaluating prognosis. With the widespread application of machine learning techniques, the present study proposed the ensemble learning method based on efficient feature representations to predict recurrence outcomes within three years after surgery. Radiomics features during arterial phase (AP) and clinical data were selected for training the ensemble models. In order to improve the efficiency of the process, the lesion area was automatically segmented by 3D U-Net. It was found that the mIoU of the segmentation model was 0.8874, and the Light Gradient Boosting Machine (LightGBM) was the most superior, with an average accuracy of 0.7600, a recall of 0.7673, a F(1) score of 0.7553, and an AUC of 0.8338 when inputting radiomics features during AP and clinical baseline indicators. Studies have shown that the proposed strategy can relatively accurately predict the recurrence outcome within three years, which is helpful for physicians to evaluate individual patients before surgery. |
format | Online Article Text |
id | pubmed-9686395 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96863952022-11-25 Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery Wang, Liyang Wu, Meilong Zhu, Chengzhan Li, Rui Bao, Shiyun Yang, Shizhong Dong, Jiahong Front Oncol Oncology Preoperative prediction of recurrence outcome in hepatocellular carcinoma (HCC) facilitates physicians’ clinical decision-making. Preoperative imaging and related clinical baseline data of patients are valuable for evaluating prognosis. With the widespread application of machine learning techniques, the present study proposed the ensemble learning method based on efficient feature representations to predict recurrence outcomes within three years after surgery. Radiomics features during arterial phase (AP) and clinical data were selected for training the ensemble models. In order to improve the efficiency of the process, the lesion area was automatically segmented by 3D U-Net. It was found that the mIoU of the segmentation model was 0.8874, and the Light Gradient Boosting Machine (LightGBM) was the most superior, with an average accuracy of 0.7600, a recall of 0.7673, a F(1) score of 0.7553, and an AUC of 0.8338 when inputting radiomics features during AP and clinical baseline indicators. Studies have shown that the proposed strategy can relatively accurately predict the recurrence outcome within three years, which is helpful for physicians to evaluate individual patients before surgery. Frontiers Media S.A. 2022-11-10 /pmc/articles/PMC9686395/ /pubmed/36439437 http://dx.doi.org/10.3389/fonc.2022.1019009 Text en Copyright © 2022 Wang, Wu, Zhu, Li, Bao, Yang and Dong https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Wang, Liyang Wu, Meilong Zhu, Chengzhan Li, Rui Bao, Shiyun Yang, Shizhong Dong, Jiahong Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery |
title | Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery |
title_full | Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery |
title_fullStr | Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery |
title_full_unstemmed | Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery |
title_short | Ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery |
title_sort | ensemble learning based on efficient features combination can predict the outcome of recurrence-free survival in patients with hepatocellular carcinoma within three years after surgery |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686395/ https://www.ncbi.nlm.nih.gov/pubmed/36439437 http://dx.doi.org/10.3389/fonc.2022.1019009 |
work_keys_str_mv | AT wangliyang ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery AT wumeilong ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery AT zhuchengzhan ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery AT lirui ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery AT baoshiyun ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery AT yangshizhong ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery AT dongjiahong ensemblelearningbasedonefficientfeaturescombinationcanpredicttheoutcomeofrecurrencefreesurvivalinpatientswithhepatocellularcarcinomawithinthreeyearsaftersurgery |